2023
Approval of 3rd Manufacturing Unit by US FDA
2022
Approval of First ANDA (OSD) from Faraaz Ayaaz Hossain Building by US FDA
First Brazil ANVISA Approved Sterile Injectable Facility in Bangladesh
First US FDA Approved Sterile Injectable Facility in Bangladesh
Export of First Injectable Product from Bangladesh to USA
2021
First Generic Nirmatrelvir & Ritonavir Combipack from Bangladesh to USA in the world to treat COVID-19 patients
First Generic Molnupiravir in the world to treat COVID-19 patients
First Brazilian ANVISA approved Oncology facility in Bangladesh
2020
First Generic Remdesivir in the world to treat COVID-19 patients
First EU GMP Approved Oncology Facility in Bangladesh
2019
Submission of First ANDA to US FDA
2018
Commissioning of Oncology Facility
2017
Commissioning of Faraaz Ayaaz Hossain Building
| Capsule | Tablet | Liquid | MDI | DPI | Topical | LVP
Accreditation of Faraaz Ayaaz Hossain Building by UK MHRA
Commissioning of Carbapenem Facility
2016
Commissioning of Rupganj Plant
| Animal Health | Sachets |
2015
Approval by UNICEF
Acquisition of Salna Plant
Approval of ISO 14001 & OHSAS 18001
| Environment | Health & Safety |
2013
Commissioning of Sterile Unit at Tongi
| Eye Drops | Vials |
2012
Accreditation by VMD UK
Starts manufacturing Insulin for Novo Nordisk
Starts production of Large Volume Parenterals
2010
Commissioning of Liquid Sterile Unit at Tongi
| Ampoules |
Accreditation by TGA Australia
2008
Accreditation by UK MHRA & EU GMP
Commissioning of Dedicated Cephalosporin Plant
2004
Entry into International Business
Commencement of production from Tongi Plant
2001
Acquisition of Squibb Plant at Tongi
Commencement of Animal Health Business
1999
Pioneering of Pellet Technology in Bangladesh
1990
Eskayef starts its journey from Mirpur Plant